JoVE - Journal of Visualized Experiments
JoVE Visualize
Contact Us

Assessing Influence of Mismatch Repair Mutations on Survival in Patients After Resection of Pancreatic Ductal and Periampullary Adenocarcinoma

  • 0Sidney Kimmel Medical College, Philadelphia, PA 19107, USA.
Journal of Clinical Medicine +

|

October 26, 2024

|

October 26, 2024

View abstract on PubMed

Summary

This summary is machine-generated.

Deficient mismatch repair (dMMR) status significantly improves survival in patients undergoing resection for pancreatic and periampullary cancer. This finding highlights dMMR as a potential prognostic marker for better oncologic outcomes.

Area Of Science

  • Oncology
  • Gastroenterology
  • Genetics

Background

  • Pancreatic ductal adenocarcinoma (PDAC) is a leading cause of cancer mortality.
  • Microsatellite instability and deficient mismatch repair (dMMR) may correlate with better survival in pancreatic cancer.
  • Investigating dMMR's impact on oncologic outcomes after PDAC and periampullary adenocarcinoma resection is crucial.

Purpose Of The Study

  • To evaluate the association between deficient mismatch repair (dMMR) status and survival outcomes.
  • To analyze the prognostic value of dMMR in patients with resected PDAC and periampullary adenocarcinoma.

Main Methods

  • Retrospective analysis of 418 patients (PDAC and periampullary adenocarcinoma) who underwent pancreatic resection (2016-2021).
  • Immunohistochemistry for MMR proteins and next-generation sequencing data were utilized.
  • Cox regression and propensity-score matching were employed to compare oncologic outcomes based on dMMR status.

Main Results

  • 3.5% of patients (15/418) were diagnosed with dMMR.
  • dMMR status was strongly associated with improved overall survival (p < 0.05).
  • Propensity-score matched analysis confirmed dMMR as a significant marker for improved overall survival (HR = 0.27, p = 0.029).

Conclusions

  • Deficient mismatch repair (dMMR) status is linked to significantly better survival after pancreatic and periampullary cancer resection.
  • dMMR may serve as a valuable prognostic indicator in these patient populations.
  • Further large-scale studies are warranted to validate these findings.

Keywords: